The Possibility of Urinary Liver-Type Fatty Acid-Binding Protein as a Biomarker of Renal Hypoxia in Spontaneously Diabetic Torii Fatty Rats

被引:16
作者
Tanabe, Jun [1 ]
Ogura, Yuji [2 ]
Nakabayashi, Mikie [3 ]
Nagai, Yoshio [4 ]
Watanabe, Shiika [1 ]
Sugaya, Takeshi [1 ]
Ohata, Keiichi [1 ]
Ichikawa, Daisuke [1 ]
Inoue, Kazuho [5 ]
Hoshino, Seiko [5 ]
Kimura, Kenjiro [6 ]
Shibagaki, Yugo [1 ]
Ono, Yumie [3 ]
Kamijo-Ikemori, Atsuko [1 ,5 ]
机构
[1] St Marianna Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Kawasaki, Kanagawa, Japan
[2] St Marianna Univ, Sch Med, Dept Physiol, Kawasaki, Kanagawa, Japan
[3] Meiji Univ, Sch Sci & Technol, Dept Elect & Bioinformat, Kawasaki, Kanagawa, Japan
[4] St Marianna Univ, Sch Med, Dept Internal Med, Div Metab & Endocrinol, Kawasaki, Kanagawa, Japan
[5] St Marianna Univ, Sch Med, Dept Anat, Kawasaki, Kanagawa, Japan
[6] JCHO Tokyo Takanawa Hosp, Tokyo, Japan
基金
日本学术振兴会;
关键词
Diabetes; Diabetic kidney disease; Hypoxia; Kidney; Liver-type fatty acid-binding protein; Tubulointerstitial damage; TUBULOINTERSTITIAL INJURY; OXYGEN-CONSUMPTION; KIDNEY-DISEASE; RECEPTOR; HYPERGLYCEMIA; NEPHROPATHY; REFLECTS;
D O I
10.1159/000503926
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Background: Renal hypoxia is an aggravating factor for tubulointerstitial damage, which is strongly associated with renal prognosis in diabetic kidney disease (DKD). Therefore, urinary markers that can detect renal hypoxia are useful for monitoring DKD. Objective: To determine the correlation between urinary liver-type fatty acid-binding protein (L-FABP) and renal hypoxia using a novel animal model of type 2 diabetes. Methods: Male spontaneously diabetic Torii (SDT) fatty rats (n = 6) were used as an animal model of type 2 diabetes. Age- and sex-matched Sprague-Dawley (SD) rats (n = 8) were used as controls. Body weight, systolic blood pressure, and blood glucose levels were measured at 8, 12, 16, and 24 weeks of age. Urine samples and serum and kidney tissues were collected at 24 weeks of age. Microvascular blood flow index (BFI) was measured using diffuse correlation spectroscopy before sampling both the serum and kidneys for the evaluation of renal microcirculation at the corticomedullary junction. Results: Obesity, hyperglycemia, and hypertension were observed in the SDT fatty rats. Focal glomerular sclerosis, moderate interstitial inflammation, and fibrosis were significantly more frequent in SDT fatty rats than in SD rats. While the frequency of peritubular endothelial cells and phosphoendothelial nitric oxide synthase levels were similar in both types of rats, the degree of renal hypoxia-inducible factor-1 alpha (HIF-1 alpha) expression was significantly higher (and with no change in renal vascular endothelial growth factor expression levels) in the SDT fatty rats. Urinary L-FABP levels were significantly higher and renal microvascular BFI was significantly lower in the SDT fatty rats than in the SD rats. Urinary L-FABP levels exhibited a significant positive correlation with renal HIF-1 alpha expression and a significant negative correlation with renal microvascular BFI. Conclusions: Urinary L-FABP levels reflect the degree of renal hypoxia in DKD in a type 2 diabetic animal model. Urinary L-FABP may thus prove useful as a renal hypoxia marker for monitoring DKD in patients with type 2 diabetes in clinical practice.
引用
收藏
页码:1476 / 1492
页数:17
相关论文
共 50 条
  • [31] Urinary Liver-Type Fatty Acid-Binding Protein Level as a Predictive Biomarker of Acute Kidney Injury in Patients with Acute Decompensated Heart Failure
    Hishikari, Keiichi
    Hikita, Hiroyuki
    Nakamura, Shun
    Nakagama, Shun
    Mizusawa, Masahumi
    Yamamoto, Tasuku
    Doi, Junichi
    Hayashi, Yosuke
    Utsugi, Yuya
    Araki, Makoto
    Sudo, Yuta
    Kimura, Shigeki
    Takahashi, Atsushi
    Ashikaga, Takashi
    Isobe, Mitsuaki
    [J]. CARDIORENAL MEDICINE, 2017, 7 (04) : 267 - 275
  • [32] Significance of urinary liver-type fatty acid-binding protein in patients with normal renal function after undergoing intestinal urinary diversion: a preliminary study
    Maehana, Takeshi
    Ichihara, Koji
    Takahashi, Satoshi
    Takahashi, Yusuke
    Hashimoto, Kohei
    Tanaka, Toshiaki
    Masumori, Naoya
    [J]. CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2021, 25 (10) : 1151 - 1157
  • [33] A newly developed kit for the measurement of urinary liver-type fatty acid-binding protein as a biomarker for acute kidney injury in patients with critical care
    Sato, Ryo
    Suzuki, Yasushi
    Takahashi, Gaku
    Kojika, Masahiro
    Inoue, Yoshihiro
    Endo, Shigeatsu
    [J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2015, 21 (3-4) : 165 - 169
  • [34] Significance of urinary liver-type fatty acid-binding protein in patients with normal renal function after undergoing intestinal urinary diversion: a preliminary study
    Takeshi Maehana
    Koji Ichihara
    Satoshi Takahashi
    Yusuke Takahashi
    Kohei Hashimoto
    Toshiaki Tanaka
    Naoya Masumori
    [J]. Clinical and Experimental Nephrology, 2021, 25 : 1151 - 1157
  • [35] Urinary liver-type fatty acid binding protein is an independent predictor of stroke and mortality in individuals with type 1 diabetes
    Panduru, Nicolae M.
    Forsblom, Carol
    Saraheimo, Markku
    Thorn, Lena M.
    Gordin, Daniel
    Elonen, Nina
    Harjutsalo, Valma
    Bierhaus, Angelika
    Humpert, Per M.
    Groop, Per-Henrik
    [J]. DIABETOLOGIA, 2017, 60 (09) : 1782 - 1790
  • [36] Incremental short maximal exercise increases urinary liver-type fatty acid-binding protein in adults without CKD
    Kosaki, Keisei
    Kamijo-Ikemori, Atsuko
    Sugaya, Takeshi
    Kumamoto, Shota
    Tanahashi, Koichiro
    Kumagai, Hiroshi
    Kimura, Kenjiro
    Shibagaki, Yugo
    Maeda, Seiji
    [J]. SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS, 2020, 30 (04) : 709 - 715
  • [37] Urinary liver-type fatty acid-binding protein: Discrimination between IgA nephropathy and thin basement membrane nephropathy
    Nakamura, T
    Sugaya, T
    Ebihara, I
    Koide, H
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2005, 25 (05) : 447 - 450
  • [38] Urinary liver type fatty acid binding protein in diabetic nephropathy
    Kamijo-Ikemori, Atsuko
    Sugaya, Takeshi
    Ichikawa, Daisuke
    Hoshino, Seiko
    Matsui, Katsuomi
    Yokoyama, Takeshi
    Yasuda, Takashi
    Hirata, Kazuaki
    Kimura, Kenjiro
    [J]. CLINICA CHIMICA ACTA, 2013, 424 : 104 - 108
  • [39] Predictive Effects of Urinary Liver-Type Fatty Acid-Binding Protein for Deteriorating Renal Function and Incidence of Cardiovascular Disease in Type 2 Diabetic Patients Without Advanced Nephropathy
    Araki, Shin-ichi
    Haneda, Masakazu
    Koya, Daisuke
    Sugaya, Takeshi
    Isshiki, Keiji
    Kume, Shinji
    Kashiwagi, Atsunori
    Uzu, Takashi
    Maegawa, Hiroshi
    [J]. DIABETES CARE, 2013, 36 (05) : 1248 - 1253
  • [40] Brain-type and liver-type fatty acid-binding proteins: new tumor markers for renal cancer?
    Toelle, Angelika
    Jung, Monika
    Lein, Michael
    Johannsen, Manfred
    Miller, Kurt
    Moch, Holger
    Jung, Klaus
    Kristiansen, Glen
    [J]. BMC CANCER, 2009, 9